Related Experiment Video
Updated: Jun 9, 2025

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
Published on: September 7, 2022
Immune Modulation by Epstein-Barr Virus Lytic Cycle: Relevance and Implication in Oncogenesis
Nevena Todorović1,2, Maria Raffaella Ambrosio3, Amedeo Amedei1,4
1Department of Experimental and Clinical Medicine, University of Florence, 50134 Florence, Italy.
Epstein-Barr virus (EBV) lytic phase, previously underestimated, is increasingly linked to cancer development. This review explores how EBV
Area of Science:
- Virology
- Oncology
- Immunology
Background:
- Epstein-Barr virus (EBV) infects over 90% of the global population, establishing lifelong infections.
- EBV infection is associated with various diseases, including lymphomas, carcinomas, multiple sclerosis, and rheumatoid arthritis.
- The role of the EBV lytic phase in oncogenesis has been historically underestimated but is gaining attention.
Purpose of the Study:
- To investigate the contribution of the Epstein-Barr virus (EBV) lytic phase to the development of EBV-associated cancers.
- To review the current understanding of how EBV lytic cycle mechanisms influence oncogenesis.
- To explore EBV's immune evasion strategies during its lytic infection.
Main Methods:
- Literature review of existing studies on EBV life cycle, oncogenesis, and immune modulation.
- Analysis of evidence implicating lytic gene expression in cancer cells.
- Synthesis of findings on the persistent stimulation of the immune system by EBV lytic activity.
Main Results:
- Evidence suggests the EBV lytic phase plays a significant role in oncogenesis, contrary to previous assumptions.
- Lytic genes are expressed in various cancer types, indicating their involvement in tumor development.
- EBV employs diverse strategies to evade immune responses during its persistent lytic activity.
Conclusions:
- The EBV lytic phase is a critical factor in EBV-driven oncogenesis.
- Further research is needed to elucidate the precise mechanisms by which the EBV lytic cycle contributes to cancer.
- Understanding EBV's immune modulation during the lytic phase is key to combating EBV-associated malignancies.
Related Concept Videos
Mitogens and the Cell Cycle
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Abnormal Proliferation
Mechanisms of Retrovirus-induced Cancers
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...

